Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 26.64 Million SEK | -2.48% |
| 2022 | 27.32 Million SEK | 69.75% |
| 2021 | 16.09 Million SEK | 94.57% |
| 2020 | 8.27 Million SEK | -63.84% |
| 2019 | 22.87 Million SEK | 13.38% |
| 2018 | 20.17 Million SEK | 42.18% |
| 2017 | 14.19 Million SEK | -15.46% |
| 2016 | 16.78 Million SEK | 59.96% |
| 2015 | 10.49 Million SEK | 455.34% |
| 2014 | 1.89 Million SEK | -42.52% |
| 2013 | 3.28 Million SEK | 271.61% |
| 2012 | -1.91 Million SEK | -81.96% |
| 2011 | -1.05 Million SEK | -130.22% |
| 2010 | 3.48 Million SEK | -33.93% |
| 2009 | 5.27 Million SEK | 397.52% |
| 2008 | -1.77 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 12.67 Million SEK | -30.49% |
| 2024 Q2 | 18.23 Million SEK | 47.64% |
| 2024 Q1 | 12.34 Million SEK | 62.3% |
| 2023 Q1 | 3.41 Million SEK | -55.54% |
| 2023 Q4 | 7.6 Million SEK | -21.53% |
| 2023 FY | 26.64 Million SEK | -2.48% |
| 2023 Q2 | 5.92 Million SEK | 73.43% |
| 2023 Q3 | 9.69 Million SEK | 63.6% |
| 2022 Q1 | 5.27 Million SEK | -10.8% |
| 2022 Q2 | 7.84 Million SEK | 48.8% |
| 2022 Q3 | 6.51 Million SEK | -17.01% |
| 2022 FY | 27.32 Million SEK | 69.75% |
| 2022 Q4 | 7.68 Million SEK | 17.98% |
| 2021 Q1 | 4 Million SEK | -9.06% |
| 2021 Q2 | 2.74 Million SEK | -31.33% |
| 2021 FY | 16.09 Million SEK | 94.57% |
| 2021 Q3 | 3.43 Million SEK | 24.81% |
| 2021 Q4 | 5.91 Million SEK | 72.37% |
| 2020 Q3 | 1.53 Million SEK | 175.28% |
| 2020 FY | 8.27 Million SEK | -63.84% |
| 2020 Q2 | -2.03 Million SEK | -146.61% |
| 2020 Q1 | 4.37 Million SEK | -9.55% |
| 2020 Q4 | 4.4 Million SEK | 186.78% |
| 2019 Q4 | 4.83 Million SEK | -39.99% |
| 2019 FY | 22.87 Million SEK | 13.38% |
| 2019 Q3 | 8.06 Million SEK | 99.46% |
| 2019 Q2 | 4.04 Million SEK | -31.97% |
| 2019 Q1 | 5.94 Million SEK | -1.74% |
| 2018 Q4 | 6.04 Million SEK | 114.82% |
| 2018 Q3 | 2.81 Million SEK | -39.6% |
| 2018 Q2 | 4.65 Million SEK | -30.06% |
| 2018 Q1 | 6.66 Million SEK | 151.93% |
| 2018 FY | 20.17 Million SEK | 42.18% |
| 2017 Q1 | 4.33 Million SEK | -16.49% |
| 2017 FY | 14.19 Million SEK | -15.46% |
| 2017 Q3 | 3.01 Million SEK | -28.06% |
| 2017 Q4 | 2.64 Million SEK | -12.39% |
| 2017 Q2 | 4.19 Million SEK | -3.25% |
| 2016 Q1 | 4.35 Million SEK | 27.29% |
| 2016 Q2 | 3.76 Million SEK | -13.44% |
| 2016 Q4 | 5.19 Million SEK | 49.28% |
| 2016 Q3 | 3.47 Million SEK | -7.67% |
| 2016 FY | 16.78 Million SEK | 59.96% |
| 2015 Q4 | 3.41 Million SEK | 108.6% |
| 2015 Q3 | 1.63 Million SEK | -32.69% |
| 2015 Q2 | 2.43 Million SEK | -18.91% |
| 2015 Q1 | 3 Million SEK | 86.75% |
| 2015 FY | 10.49 Million SEK | 455.34% |
| 2014 Q4 | 1.6 Million SEK | 1040.43% |
| 2014 Q1 | 322 Thousand SEK | -69.25% |
| 2014 Q2 | -181 Thousand SEK | -156.21% |
| 2014 Q3 | 141 Thousand SEK | 177.9% |
| 2014 FY | 1.89 Million SEK | -42.52% |
| 2013 FY | 3.28 Million SEK | 271.61% |
| 2013 Q4 | 1.04 Million SEK | -36.16% |
| 2013 Q3 | 1.64 Million SEK | 223.31% |
| 2013 Q2 | -1.33 Million SEK | -169.02% |
| 2013 Q1 | 1.92 Million SEK | 1040.0% |
| 2012 FY | -1.91 Million SEK | -81.96% |
| 2012 Q2 | -2.39 Million SEK | -7809.68% |
| 2012 Q3 | 650 Thousand SEK | 127.2% |
| 2012 Q4 | -205 Thousand SEK | -131.54% |
| 2012 Q1 | 31 Thousand SEK | 101.87% |
| 2011 Q4 | -1.65 Million SEK | -373.15% |
| 2011 Q1 | 1.1 Million SEK | -84.44% |
| 2011 FY | -1.05 Million SEK | -130.22% |
| 2011 Q3 | 607 Thousand SEK | 154.83% |
| 2011 Q2 | -1.1 Million SEK | -200.18% |
| 2010 Q2 | -2.06 Million SEK | -94.45% |
| 2010 Q1 | -1.06 Million SEK | -156.99% |
| 2010 Q3 | -485 Thousand SEK | 76.56% |
| 2010 Q4 | 7.1 Million SEK | 1564.54% |
| 2010 FY | 3.48 Million SEK | -33.93% |
| 2009 Q1 | 3.01 Million SEK | 0.0% |
| 2009 Q3 | -713 Thousand SEK | -159.92% |
| 2009 Q2 | 1.19 Million SEK | -60.57% |
| 2009 FY | 5.27 Million SEK | 397.52% |
| 2009 Q4 | 1.86 Million SEK | 361.85% |
| 2008 Q2 | -2.88 Million SEK | -495.88% |
| 2008 Q1 | 729 Thousand SEK | 0.0% |
| 2008 FY | -1.77 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.83 Million SEK | 134.232% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 74.255% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 74.255% |
| Arcoma AB | 2.56 Million SEK | -939.236% |
| Bactiguard Holding AB (publ) | -138.38 Million SEK | 119.255% |
| BICO Group AB (publ) | -835.7 Million SEK | 103.188% |
| Boule Diagnostics AB (publ) | 24.97 Million SEK | -6.682% |
| CellaVision AB (publ) | 130.3 Million SEK | 79.552% |
| Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | 133.394% |
| Chordate Medical Holding AB (publ) | -29.18 Million SEK | 191.295% |
| C-Rad AB (publ) | 35.52 Million SEK | 25.002% |
| Duearity AB (publ) | -26.19 Million SEK | 201.741% |
| Dignitana AB (publ) | -17.36 Million SEK | 253.464% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 128.108% |
| Getinge AB (publ) | 2.41 Billion SEK | 98.895% |
| Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | 139.198% |
| Iconovo AB (publ) | -45.89 Million SEK | 158.06% |
| Integrum AB (publ) | 4.03 Million SEK | -560.785% |
| Luxbright AB (publ) | -25.37 Million SEK | 205.008% |
| Mentice AB (publ) | -2.81 Million SEK | 1045.9% |
| OssDsign AB (publ) | -130.49 Million SEK | 120.419% |
| Paxman AB (publ) | 8.33 Million SEK | -219.88% |
| Promimic AB (publ) | -9.22 Million SEK | 388.939% |
| Qlife Holding AB (publ) | -159.95 Million SEK | 116.658% |
| SciBase Holding AB (publ) | -55.58 Million SEK | 147.937% |
| ScandiDos AB (publ) | -14.64 Million SEK | 281.921% |
| Sectra AB (publ) | 428.38 Million SEK | 93.78% |
| Sedana Medical AB (publ) | -59.61 Million SEK | 144.699% |
| Senzime AB (publ) | -134.14 Million SEK | 119.863% |
| SpectraCure AB (publ) | -20.44 Million SEK | 230.356% |
| Vitrolife AB (publ) | -3.85 Billion SEK | 100.692% |
| Xvivo Perfusion AB (publ) | 91.82 Million SEK | 70.98% |